Microbiology & Infectious Diseases

COVID-19 vaccination is strongly recommended for immunocompromised patients for the 2025–2026 season, according to new guidance.

Uncomplicated UTIs disrupt lives as recurrence and antimicrobial resistance complicate antibiotic choice for clinicians’ daily care.

Long-acting injectable antiretroviral therapy may ease pill burden, improve adherence, and privacy in Pakistan, interviews suggest.

Mpox-HIV coinfection in MSM was linked to more severe symptoms and higher hospitalization, in Hangzhou case series of 104 patients.

Persistent portal hypertension after HCV cure characterized immunological mechanisms differing by HIV status in advanced cirrhosis.

Chikungunya outbreak risk is surging as Aedes vectors proliferate transcontinentally, while vaccines attain authorizations in 2025.

Dengue infection raised two-year hospitalization risk and added measurable disability burden in Singapore’s linked national cohort.

Pediatric influenza hospitalizations shifted after the COVID-19 pandemic, with altered seasonality, virus type, and shorter stays.